Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies

Psychopharmacology (Berl). 2000 Jan;148(1):22-3. doi: 10.1007/s002130050020.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / therapeutic use
  • Basal Ganglia Diseases / drug therapy
  • Dose-Response Relationship, Drug
  • Humans
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / metabolism
  • Tomography, Emission-Computed

Substances

  • Antipsychotic Agents
  • Receptors, Dopamine D2